NCT06986772Befejeződött1. fázis
TGRX-678 Pharmacokinetic Mass Balance
[14C]TGRX-678 Mass Balance Study in Chinese Healthy Male Adults
Forrás: ClinicalTrials.gov · Utoljára frissítve: 2025. szept. 4.
Rövid összefoglaló (regiszter, angolul)
This is a pharmacokinetic study for [14C]TGRX-678 on mass balance to evaluate distribution, metabolism and excretion of TGRX-678, a tyrosine kinase inhibitor indicated for treatment of chronic myeloid leukemia.
- Állapot (regiszter)
- Befejeződött
- Fázis (regiszter)
- 1. fázis
- Vizsgálattípus
- Beavatkozással járó
- Résztvevők száma
- 6 (tényleges)
- Első benyújtás
- 2025. máj. 15.
- Kezdés
- 2025. júl. 7.
- Elsődleges befejezés
- 2025. aug. 17.
- Fő szponzor
- Shenzhen TargetRx Co., Ltd.
- NCT-szám
- NCT06986772
Mit vállalsz
- Vizsgálat típusa: Beavatkozással járó · 1. fázis
- Bevont résztvevők: 6
- 2025. júl. 7. és az elsődleges befejezés (2025. aug. 17.) között
- 1 helyszín, 1 országban
- Vizitek és vizsgálatok: kérdezd a vizsgálat csapatát, a regiszter nem sorolja fel őket
A(z) ClinicalTrials.gov regisztermezőiből összeállítva. A vizsgálat felépítését írja le.
Ki nem vehet részt
Szó szerint a(z) ClinicalTrials.gov forrásból, témák szerint csoportosítva. Hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.
Korábbi kezelés
- usage of any inducers or inhibitors for drug metabolism enzymes (especially CYP3A4) within 30 days of screening
- received major surgery or with un-healed surgical wounds within 6 months of screening
- have allergies to at least 2 substances or at investigator's discretion may be allergic to investigational drug or any excipients
- drug abuse, or use of soft drug (marajuana) within 3 months of screening, or use of hard drug (phenylamine or PCP type drugs) within 1 year of screening, or tested positive in urine drug test during screening
- habitutory use of grape fruit juice, or overuse of tea, coffee or caffeinated drugs, and cannot quit during study
- Participation in any other clinical studies within 3 months before screening
- Reception of vaccine within 1 months before screening, or planning to be vaccinated during the study
- Blood donation or blood loss of > 400 ml within 3 months before screening; blood donation or blood loss of > 200 ml within 1 month before screening; reception of blood transfusion within 1 months before screening; received blood donation within 1 months of study, or planning to donate blood within 3 months after study completion
Más betegség
- positive test results on hepatitis B surface antigen/ E antigen, hepatitis C antibody, HIV antigen/antibody or syphylus antibody
- history of any clinically significant serious diseases or any conditions that at investigator's discretion may affect study results
- have condition that may affect drug absoption
- have hemorrhoids; have history of or is having conditions that cause bloody feces, irritable bowel syndrome, or inflammatory bowel disease
- long-term occupational exposure to radioactive conditions, or have history of significant radioactive substance exposure or participated in clinical study using radioactive-labeled drugs within 1 year of current study
- Having difficulties to receive venous needle puncture, or cannot tolerate venous needle puncture, or history of hematophobia or needle sickness
- Any conditions that the investigator deemed unfit for the study
Laborértékek
- abnormal and of clinical significance results on physical exam, regular laboratory tests, thyroid function, anal check, chest x-ray, abdominal ultrasound check or 12-lead ECG
- usage of any prescriptional drug, OTC drug, herbal medicine, traditional Chinese medicine, or food supplements (i.e., vitamins, calcium) within 14 days of screening
Egyéb
- abnornal and of clinical significance results on eye exam
- habitutory constipation or diarrhea
- alcohol abuse, or frequent use of alcohol within 6 months of screening
- smoking of more than 5 cigarettes per day within 3 months of screening, or habitutory use of nicotine products and cannot quit during study
- Planning to have children or donate sperms during the study and within 1 year after the study, or Not agreeing to take contraceptive measures during and within 1 year after study completion
- Having special dietary requirements and unable to follow the uniform dietary plan in the study
Kiket keres a vizsgálat
- Healthy adult males
- age between 18 and 45 (both included) years old
- body weight index between 19.0 and 26.0 kg/m2 (both included, and body weight not lower than 50 kg
- can volunteeringly consent
- can communicate well with investigators and complete study according to protocol requirements
Életkor a regiszterben: 18 év – 45 év · Nem: csak férfiak · Egészséges önkénteseket is fogad
Helyszínek (1)
Helyszínek a regiszter sorrendjében. Ha a profilodba mented a városodat, távolság szerint rendeződnek.
| Helyszín | Város | Ország | Helyszín állapota |
|---|---|---|---|
| The First Affiliated Hospital of Soochow University | Suzhou | Kína | Ismeretlen állapot |
Ez az oldal tájékoztatás, nem orvosi tanács. Bármely vizsgálatról az orvosoddal beszélj.